Adjuvant Atezolizumab Impact on Recurrence Prevention and Cost Reduction in Early PD-L1 High NSCLC
Recurrent cases of non-small cell lung cancer (NSCLC) following surgery are common and carry significant morbidity and mortality risks. A recent study assessed the effe...